Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of Nephrology
Published in: Journal of Nephrology 4/2014

01-08-2014 | Letter to the Editor

Fluctuation of serum C3 levels reflects disease activity and metabolic background in patients with IgA nephropathy: response to comment

Author: Yasuhiko Tomino

Published in: Journal of Nephrology | Issue 4/2014

Login to get access

Excerpt

Dear Editor, …
Literature
1.
Suzuki H, Ohsawa I, Kodama F, Nakayama K, Ohtani A, Onda K, Nagamachi S, Kurusu A, Suzuki Y, Ohi H, Horikoshi S, Tomino Y (2013) Fluctuation of serum C3 levels reflects disease activity and metabolic background in patients with IgA nephropathy. J Nephrol 26(4):708–715. doi:10.​5301/​jn.​5000278 PubMedCrossRef
2.
Sakallioglu O (2014) Comment on the article ‘Fluctuation of serum C3 levels reflects disease activity and metabolic background in patients with IgA nephropathy’. J Nephrol. doi:10.​1007/​s40620-014-0104-x
Metadata
Title
Fluctuation of serum C3 levels reflects disease activity and metabolic background in patients with IgA nephropathy: response to comment
Author
Yasuhiko Tomino
Publication date
01-08-2014
Publisher
Springer International Publishing
Published in
Journal of Nephrology / Issue 4/2014
Print ISSN: 1121-8428
Electronic ISSN: 1724-6059
DOI
https://doi.org/10.1007/s40620-014-0088-6

Other articles of this Issue 4/2014

Journal of Nephrology 4/2014 Go to the issue

Original Article

Accuracy of the estimation of glomerular filtration rate within a population of critically ill patients

Review

Metabolic syndrome and nephrolithiasis: a systematic review and meta-analysis of the scientific evidence

Erratum

Erratum to: Proteomics and diabetic nephropathy: what have we learned from a decade of clinical proteomics studies?

Original Article

Reinitiation of peritoneal dialysis after catheter removal for refractory peritonitis

Case Report

A novel CFHR5 mutation associated with C3 glomerulonephritis in a Turkish girl

Letter to the Editor

Comment on Suzuki et al.: “Fluctuation of serum C3 levels reflects disease activity and metabolic background in patients with IgA nephropathy”
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits